Eagle Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-328,179
Closed -$33.9M 583
2023
Q3
$33.9M Buy
328,179
+286
+0.1% +$29.5K 0.2% 140
2023
Q2
$39.8M Buy
327,893
+174,284
+113% +$21.2M 0.22% 134
2023
Q1
$23.6M Sell
153,609
-51
-0% -$7.83K 0.14% 153
2022
Q4
$27.5M Buy
153,660
+407
+0.3% +$72.8K 0.17% 147
2022
Q3
$18.1M Buy
153,253
+944
+0.6% +$112K 0.12% 178
2022
Q2
$21.8M Buy
152,309
+3,230
+2% +$461K 0.14% 173
2022
Q1
$25.7M Buy
149,079
+294
+0.2% +$50.6K 0.13% 176
2021
Q4
$37.4M Buy
148,785
+929
+0.6% +$234K 0.16% 167
2021
Q3
$56.9M Sell
147,856
-227,725
-61% -$87.6M 0.26% 143
2021
Q2
$88.3M Sell
375,581
-483,231
-56% -$114M 0.38% 105
2021
Q1
$114M Buy
858,812
+198,264
+30% +$26.3M 0.5% 68
2020
Q4
$69M Sell
660,548
-54,306
-8% -$5.67M 0.39% 91
2020
Q3
$50.4M Sell
714,854
-2,537
-0.4% -$179K 0.26% 143
2020
Q2
$44.5M Buy
+717,391
New +$44.5M 0.25% 145